G. Amminger

发表

Age of onset of mental disorders: a review of recent literature

T. B. Üstün, R. Kessler, Sing Lee, 2007, Current opinion in psychiatry.

Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care

P. McGorry, R. Purcell, G. Amminger, 2011, Current opinion in psychiatry.

Is basic self‐disturbance in ultra‐high risk for psychosis (‘prodromal’) patients associated with borderline personality pathology?

A. Yung, B. Nelson, A. Thompson, 2013, Early intervention in psychiatry.

Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?

S. Hetrick, K. Allott, G. Amminger, 2016, Brain and behavior.

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder.

P. Fitzgerald, M. Berk, Sung-Wan Kim, 2014, Journal of affective disorders.

PACE: a specialised service for young people at risk of psychotic disorders

A. Yung, L. Phillips, S. Francey, 2007, The Medical journal of Australia.

Experience of trauma and conversion to psychosis in an ultra‐high‐risk (prodromal) group

A. Bechdolf, S. Francey, B. Nelson, 2010, Acta psychiatrica Scandinavica.

Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence

P. DeRosse, A. Malhotra, P. Szeszko, 2017, Neuroscience.

Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder.

M. Berk, J. Klosterkötter, A. Bechdolf, 2012, Current pharmaceutical design.

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study

G. Jackson, C. Pantelis, D. Velakoulis, 2008, Neuropsychopharmacology.

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults.

M. Berk, A. Bechdolf, A. Yung, 2010, Journal of affective disorders.

Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years

A. Yung, P. McGorry, H. Herrman, 2011, Psychological Medicine.

Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.

C. Davey, I. McGregor, P. McGorry, 2022, The Journal of clinical psychiatry.

Update on Omega-3 Polyunsaturated Fatty Acids in Early-Stage Psychotic Disorders

Patrick D McGorry, G. Koob, E. Zorrilla, 2012, Neuropsychopharmacology.

Baseline data of a sequential multiple assignment randomized trial (STEP study)

C. Carter, T. Niendam, H. Yuen, 2022, Early intervention in psychiatry.

Associations of obsessive–compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

M. Berk, Sung-Wan Kim, P. McGorry, 2015, Psychiatry Research.

Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia

J. Reichenbach, H. Sauer, S. Smesny, 2015, European Neuropsychopharmacology.

Transitions Study of predictors of illness progression in young people with mental ill health: study methodology

A. Mackinnon, A. Guastella, I. Hickie, 2015, Early intervention in psychiatry.

Treated incidence of first‐episode psychosis in the catchment area of EPPIC between 1997 and 2000

M. Lambert, H. Yuen, P. McGorry, 2006, Acta psychiatrica Scandinavica.

The Addition of Fish Oil to Cognitive Behavioural Case Management for Youth Depression (YoDA-F): A Randomised, Double-Blind, Placebo-Controlled, Multicentre Clinical Trial

A. Mackinnon, I. Hickie, D. Hermens, 2023, Biological Psychiatry.

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder.

P. Fitzgerald, M. Berk, Sung-Wan Kim, 2014, Journal of affective disorders.